New RU 486 controversy!
The RU 486 so called 'chemical abortion' requires the administration of two medications. One of them is an ulcer medication which is not often used. The Population Council who is pushing this type of abortion, ran into a snag when no American manufacturer wanted to produce the main medication and this was solved by entering a buying agreement with a Chinese pharmaceutical. However, the second medication, an ulcer medication, Misoprostol or (brand name) Cytotec, which is not often used, is also required for a chemical abortion. This medication, made by Searle, a satelite of Monsanto, has a contraindication of administration to pregnant women because (as stated in the letter below), Searle notes that Misoprostol can cause death of the baby AND/OR the mother! Just another proof that "Planned Parenthood" and other sellers of abortion, who sell their wares predicated on a caring for women, actually don't hesitate to suggest something very lifethreatening for the mother. Searle was upset enough about this, to send out this letter of concern to all medical providers in the United States: (and when a pharmaceutical company actually thinks a drug is so dangerous that it sends warnings about it despite the possible increase in sales, it should be not considered lightly):
(Searle notes that the FDA is recommending an 'off label' usage of this drug meaning giving the drug for purposes actually contraindicated by the manufacturer).
August 23, 2000 Re:Cytotec® (misoprostol) IMPORTANT DRUG WARNING Dear Health Care Provider: The purpose of this letter is to remind you that Cytotec administration by any route is contraindicated in women who are pregnant because it can cause abortion. Cytotec is not approved for the induction of labor or abortion. Cytotec is indicated for the prevention of NSAID (nonsteroidal anti-inflammatory drugs, including aspirin)-induced gastric ulcers in patients at high risk of complications from gastric ulcer, e.g., the elderly and patients with concomitant debilitating disease, as well as patients at high risk of developing gastric ulceration, such as patients with a history of ulcer. The uterotonic effect of Cytotec is an inherent property of prostaglandin E1(PGE1), of which Cytotec is stable, orally active, synthetic analog. Searle has become aware of some instances where Cytotec, outside of its approved indication, was used as a cervical ripening agent prior to termination of pregnancy, or for induction of labor, in spite of the specific contraindications to its use during pregnancy. Serious adverse events reported following off-label use of Cytotec in pregnant women include maternal or fetal death; uterine hyperstimulation, rupture or perforation requiring uterine surgical repair, hysterectomy or salpingo-oophorectomy; amniotic fluid embolism; severe vaginal bleeding, retained placenta, shock, fetal bradycardia and pelvic pain. Searle has not conducted research concerning the use of Cytotec for cervical ripening prior to termination of pregnancy or for induction of labor, nor does Searle intend to study or support these uses. Therefore, Searle is unable to provide complete risk information for Cytotec when it is used for such purposes. In addition to the known and unknown acute risks to the mother and fetus, the effect of Cytotec on the later growth, development and functional maturation of the child when Cytotec is used for induction of labor or cervical ripening has not been established. Searle promotes the use of Cytotec only for its approved indication. Please read the enclosed updated complete Prescribing Information for Cytotec. Further information may be obtained by calling 1-800-323-4204. Michael Cullen, MD Searle |